SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Polymedix, Inc – ‘10-K’ for 12/31/07 – ‘EX-31.1’

On:  Thursday, 3/27/08, at 4:37pm ET   ·   For:  12/31/07   ·   Accession #:  893220-8-876   ·   File #:  0-51895

Previous ‘10-K’:  None   ·   Next:  ‘10-K’ on 3/23/09 for 12/31/08   ·   Latest:  ‘10-K’ on 3/13/12 for 12/31/11

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/27/08  Polymedix, Inc                    10-K       12/31/07    5:649K                                   Bowne - Bop/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K Polymedix, Inc                            HTML    530K 
 2: EX-23.1     Consent of Deloitte & Touche LLP                    HTML      6K 
 3: EX-31.1     CEO Certification Pursuant to Section 302           HTML     10K 
 4: EX-31.2     CFO Certification Pursuant to Section 302           HTML     11K 
 5: EX-32       Certification Pursuant to Section 906               HTML      8K 


EX-31.1   —   CEO Certification Pursuant to Section 302


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  exv31w1  

 

Exhibit 31.1
Certification of Principal Executive Officers
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Nicholas Landekic, hereby certify that:
1. I have reviewed this annual report on Form 10-K of PolyMedix, Inc.;
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
     a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
     b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
     d) disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
     a) all deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 C:  C:  C:  C: 
                 
  By:   /s/   Nicholas Landekic
 
Nicholas Landekic
President & Chief Executive Officer
   

 


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/27/08None on these Dates
For Period End:12/31/07
 List all Filings 
Top
Filing Submission 0000893220-08-000876   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 12:40:14.1am ET